Cytological research
Researchers at Nanjing Medical University have discovered that the 70kDa ribosomal S6 kinase 1 (p70S6K1) is a crucial regulator of angiogenesis, the process by which new blood vessels form from pre-existing ones, in ovarian cancer. Specifically, p70S6K1 promotes the expression of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor 1
Cytological research
Researchers at Johns Hopkins University have made a significant breakthrough in understanding the biological mechanisms underlying osteoarthritis (OA). According to their study published in the Journal of Biological Chemistry, mechanical overloading of cartilage, characterized by high fluid shear stress, can lead to the release of pro-inflammatory mediators, matrix degradation, and
Cytological research
The plethora of novel agents recently approved for the management of metastatic renal cell carcinoma (RCC) has transformed the therapeutic landscape in this disease. These agents target various pathways, resulting in a wide range of side effects. While direct VEGF inhibition with anti-VEGF monoclonal antibodies is primarily associated with specific
Cytological research
Researchers from Japan have revealed the vital role of nitric oxide signaling in the antioxidant adaptive response. The study, published in the Journal of Biological Chemistry, demonstrates that nitric oxide (NO) triggers the formation of 8-nitroguanosine 3',5'-cyclic monophosphate (8-nitro-cGMP), a nitrated guanine nucleotide that causes protein
Cytological research
Researchers in Taichung, Taiwan, have investigated the signaling pathways associated with microtubule interaction and apoptosis in human leukemia U937 cells. They used 6-pyrrolidinyl-2-(2-hydroxyphenyl)-4-quinazolinone (MJ-29) to induce growth inhibition and cell death in leukemia cell lines. The study found that MJ-29 interacted with alpha-and beta-tubulin, inhibited tubulin polymerization, and
Cytological research
Non-muscle myosin II (NM II) plays a crucial role in cellular processes, including survival and apoptosis in response to TNF-alpha (TNF). However, the mechanisms by which NM II isoforms mediate these processes are not fully understood. Recent research published in the Journal of Cellular Biochemistry has shed light on the
Cytological research
Recent research from the United States has uncovered a novel mechanism by which interferon-gamma (IFN-gamma) can alter how cells respond to subsequent extracellular signals. According to findings published in Molecular Biology of the Cell, the IFN-gamma-induced protein murine guanylate-binding protein-2 (mGBP-2) inhibits cell spreading and signaling pathways, specifically rac activation
Cytological research
Researchers at Louisiana State University Health Sciences Center have made a significant breakthrough in understanding the aggressiveness of basal cell carcinoma. By studying the expression of various gene products in basal cell carcinomas (n=30) and non-aggressive basal cell carcinomas (n=33), the team found that stromal expression of alpha-smooth
Cytological research
Researchers at the University of Pennsylvania's Center for Animal Transgenesis and Germ Cell Research have identified a crucial component in the Piwi-interacting RNA (piRNA) pathway. The study, published in Proceedings of the National Academy of Sciences of the United States of America, reveals that MOV10L1, a germ cell-specific
Cytological research
A recent study has shed light on the relationship between the FBLN-3 gene and non-small cell lung carcinoma (NSCLC), a type of lung cancer that is often aggressive and difficult to treat. The research, published in the journal Lung Cancer, investigated the promoter methylation status of the FBLN-3 gene in
Cytological research
Researchers in the United States have conducted a study on the accuracy and cost-effectiveness of cervical cancer screening strategies based on high-risk human papillomavirus (HPV) DNA testing of self-collected vaginal samples. The study, which involved a subset of 1,665 women aged 18-50, compared five different screening strategies, including high-risk
Cytological research
Researchers at Johns Hopkins University, led by J.R. Brahmer, have published a study in the Journal of Clinical Oncology detailing the safety and efficacy of a new treatment that blocks the PD-1 immune checkpoint in patients with refractory solid tumors. The study, which involved 39 patients with various types
